Endoscopic ultrasound-guided ethanol ablation of pancreatic neuroendocrine tumours: A case study and literature review

Table 3 Procedural outcomes

No. of treatment session per tumor
Mean (range)	1.43 (1-3)
Alcohol volume, mL
Mean (range)	1.83 (0.18-8)
Technical success, n (%)	30/30 (100)
Clinical success1, n (%)
Functioning	19/19 (100)
Non functioning2	7/10 (70)
Adverse events3, n (%)	11 (25.5)
Early (within one week), n (%)	9 (21)
Pancreatic necrotic lesion	1 (2.3)
Mild pancreatitis	7 (16.2)
Abdominal pain	1 (2.3)
Late, n (%)	2 (4.6)
Hematoma and ulceration of the duodenal wall	1 (2.3)
Main pancreatic duct stricture	1 (2.3)
Follow-up, mo
Mean (range)	13.4 (2-38)

¹Clinical success: Symptom resolution for functioning tumours and radiological ablation for non-functioning tumour;

²One non functioning tumor was lost to follow-up;

³Adverse events percentage is intended in relation to procedure number.